Kyverna Therapeutics Inc.

NASDAQ: KYTX · Real-Time Price · USD
3.28
-0.19 (-5.48%)
At close: Jun 27, 2025, 3:59 PM
3.28
0.00%
After-hours: Jun 27, 2025, 05:50 PM EDT
-5.48%
Bid 3.1
Market Cap 141.76M
Revenue (ttm) n/a
Net Income (ttm) -145.42M
EPS (ttm) -3.24
PE Ratio (ttm) -1.01
Forward PE -0.98
Analyst Buy
Ask 3.62
Volume 770,648
Avg. Volume (20D) 350,246
Open 3.55
Previous Close 3.47
Day's Range 3.23 - 3.75
52-Week Range 1.78 - 11.40
Beta 2.54

About KYTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KYTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KYTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+13.66%
Kyverna Therapeutics shares are trading higher aft... Unlock content with Pro Subscription
11 months ago
+1.23%
Kyverna Therapeutics shares are trading higher after the company announced it received FDA Regenerative Medicine Advanced Therapy designation for KYV-101 in the treatment of patients with refractory stiff-person syndrome.